NCT02654093View on ClinicalTrials.gov

A Drug-drug Interaction Study of DP-R213

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Healthy

Interventions

DRUG

Cholecalciferol

DRUG

Raloxifene

DRUG

Cholecalciferol and Raloxifene co-administration

Trial Locations (1)

41940

Kyungbook National University Hospital, Jung-gu

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alvogen Korea

INDUSTRY